A Phase 1 Study to Evaluate the Safety, Tolerability

Project: Research project

Description

A Phase 1 Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of PF-06342674 (RN168) in Adults with Type 1 Diabetes
StatusFinished
Effective start/end date4/1/149/30/18

Funding

  • PFIZER, INC.

Fingerprint

Type 1 Diabetes Mellitus
Pharmacokinetics
Safety